Matches in Wikidata for { <http://www.wikidata.org/entity/Q66043308> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66043308 description "clinical trial" @default.
- Q66043308 description "ensayu clínicu" @default.
- Q66043308 description "klinisch onderzoek" @default.
- Q66043308 description "клінічне випробування" @default.
- Q66043308 name "TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer" @default.
- Q66043308 name "TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer" @default.
- Q66043308 type Item @default.
- Q66043308 label "TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer" @default.
- Q66043308 label "TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer" @default.
- Q66043308 prefLabel "TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer" @default.
- Q66043308 prefLabel "TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer" @default.
- Q66043308 P1132 Q66043308-9993C48C-C233-4F79-A80C-8C22759521D0 @default.
- Q66043308 P1476 Q66043308-113E465E-F045-4976-97AE-C5BB683F2EA4 @default.
- Q66043308 P17 Q66043308-46C5246E-8BF7-4C2D-B1E6-C171543A8989 @default.
- Q66043308 P2899 Q66043308-542502A0-F5D7-4F89-BCDA-0D06A83FF29B @default.
- Q66043308 P3098 Q66043308-1C8830CF-D35E-436D-9D31-C6E2E36200A1 @default.
- Q66043308 P31 Q66043308-80D1A73F-97CB-4236-B554-56B286E41A98 @default.
- Q66043308 P4844 Q66043308-D471BA5D-AEE9-4B94-A7C3-32AF35F86A63 @default.
- Q66043308 P4844 Q66043308-F8E8D071-EF90-4945-8757-F7A5AF2143F3 @default.
- Q66043308 P580 Q66043308-86E545AB-B475-494D-8016-CC9B9D956EE4 @default.
- Q66043308 P582 Q66043308-F01A13B9-2C00-4BB8-AB1D-8271D8D88BB1 @default.
- Q66043308 P6099 Q66043308-901E52C4-FF15-49A5-9F02-502667FBEB89 @default.
- Q66043308 P8363 Q66043308-25DA7786-8AE6-408F-9F72-3070F6A72B29 @default.
- Q66043308 P1132 "+20" @default.
- Q66043308 P1476 "Phase II Clinical Trial of Treatment With TAK-228 and TAK-117 to Inhibit Homologous Recombination (HR) Followed by Cisplatin and Nab Paclitaxel in Patients With Chemotherapy-pretreated Metastatic Triple Negative Breast Cancer" @default.
- Q66043308 P17 Q30 @default.
- Q66043308 P2899 "+18" @default.
- Q66043308 P3098 "NCT03193853" @default.
- Q66043308 P31 Q30612 @default.
- Q66043308 P4844 Q412415 @default.
- Q66043308 P4844 Q423762 @default.
- Q66043308 P580 "2017-07-18T00:00:00Z" @default.
- Q66043308 P582 "2021-06-09T00:00:00Z" @default.
- Q66043308 P6099 Q42824440 @default.
- Q66043308 P8363 Q78089383 @default.